These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 193510)

  • 21. Estrogen receptor in the mammalian liver.
    Eisenfeld AJ; Aten R; Weinberger M; Haselbacher G; Halpern K; Krakoff L
    Science; 1976 Feb; 191(4229):862-5. PubMed ID: 175442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
    Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
    Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of estrogens as postcoital contraceptive agents. Clinical effectiveness and potential mode of action.
    Blye RP
    Am J Obstet Gynecol; 1973 Aug; 116(7):1044-50. PubMed ID: 4577932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menstrual regulation by sequential hormone therapy.
    Beaton JH
    West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
    Hausmann L; Goebel KM; Zehner J
    Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogens and the hypothalamo-pituitary-adrenal axis in man: evidence for normal feedback regulation by corticosteroids.
    Baumann G
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1193-7. PubMed ID: 6630413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated intravascular coagulation induced by progesterone in the pregnant rat. Prevention by estogens.
    Stamler FW
    Am J Pathol; 1977 Mar; 86(3):603-22. PubMed ID: 65916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma norepinephrine during the rat estrous cycle and after progesterone treatment to the ovariectomized estrogen-primed rat.
    Nagle CA; Rosner JM
    Neuroendocrinology; 1976; 22(1):89-96. PubMed ID: 1035969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced hypertension: pathogenesis and management.
    Stokes GS
    Drugs; 1976; 12(3):222-30. PubMed ID: 185040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contraception in hypertensive women using a vaginal ring delivering estradiol and levonorgestrel.
    Elkik F; Basdevant A; Jackanicz TM; Guy-Grand B; Mercier-Bodard C; Conard J; Bardin CW; Corvol P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):29-35. PubMed ID: 3086360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on ethanol and oral contraceptives: feasibility of a hepatic-gonadal link.
    Messiha FS; Lox CD; Heine W
    Res Commun Subst Abuse; 1980; 1(3):315-33. PubMed ID: 12310979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Anovlar in gynaecological disorders and contraception.
    Shahani SM; Chiklikar A
    J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanism of action of the copper intrauterine device.
    Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
    Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.